8AP Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Agios Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 23.4 EUR -1.68%

Market Cap: €770.5m

A	Agios Pharmaceuticals Inc SWB:8AP	US
	Bath & Body Works Inc F:LTD0	US
M	Metro Inc F:62M	CA
	GQG Partners Inc F:6P1	US
R	Recruit Holdings Co Ltd SWB:1RH	JP
J	Jabil Inc XMUN:JBL	US
I	Indofood Sukses Makmur Tbk PT XBER:ISM	ID

Profitability Summary

Agios Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

90%

Strong 3Y Average Gross Margin

89%

Gross Margin is Increasing

90% > 90%

Negative Operating Margin

-720%

Negative 3Y Average Operating Margin

-777%

Operating Margin is Increasing

-1 990% > -720%

Negative Net Margin

-640%

Negative 3Y Average Net Margin

-54%

Net Margin is Increasing

-1 146% > -640%

Negative Free Cash Flow Margin

-582%

Negative 3Y Average Free Cash Flow Margin

-1 016%

Free Cash Flow Margin is Increasing

-1 627% > -582%

Negative ROE

-33%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-56%

ROIC is Increasing

-94% > -88%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.